These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4165545)

  • 1. [Supervision of anticoagulant therapy with the aid of the factor X determination].
    Dahl J; Remde W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(1):96-102. PubMed ID: 4165545
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulant activity of Heraclenin.
    Mishra KC; Sharma RC; Sharma YN; Arora RB
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of blood coagulation factors under the effect of a new pyrazol derivative during prolonged anticoagulant therapy].
    Wolf H
    Arzneimittelforschung; 1970 Sep; 20(9):1252-8. PubMed ID: 4098759
    [No Abstract]   [Full Text] [Related]  

  • 7. [Animal experimental tests of the prothrombin synthesis inhibition effect of coumarin derivatives].
    Markwardt F; Haustein KO
    Acta Biol Med Ger; 1966; 17(3):318-26. PubMed ID: 5987646
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of coumarin drugs upon plasma thromboplastin component.
    MCELFRESH AE; OZGE A
    J Lab Clin Med; 1957 May; 49(5):753-5. PubMed ID: 13416734
    [No Abstract]   [Full Text] [Related]  

  • 9. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
    Bourgain RH; Vanden Driessche R; Smets P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].
    Fischer M; Falkensammer C
    Wien Klin Wochenschr; 1974 Oct; 86(19):577-83. PubMed ID: 4432516
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS; Ruymann FB; Conrad ME
    J Lab Clin Med; 1971 Jan; 77(1):23-32. PubMed ID: 5540427
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical induction of fibrinolysis and inhibition of platelet aggregation (with special respect to effect of nonsteroid antiinflammatory drugs).
    Cepelák V; Roubal Z; Cepeláková H; Nĕmecek O
    Acta Univ Carol Med Monogr; 1972; 52():41-7. PubMed ID: 4669825
    [No Abstract]   [Full Text] [Related]  

  • 14. Determinants of the response to oral anticoagulant drugs in man.
    O'Reilly RA; Aggeler PM
    Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
    [No Abstract]   [Full Text] [Related]  

  • 15. The liver and blood coagulation: physiology and pathology.
    Roberts HR; Cederbaum AI
    Gastroenterology; 1972 Aug; 63(2):297-320. PubMed ID: 4558715
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of plasma fraction I-O, ACC 76, PAMBA and haemarctin on the blood coagulation system of premature newborn infants].
    Rogner G
    Z Kinderheilkd; 1967; 101(3):230-41. PubMed ID: 5626847
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of pelentan (ethyl dihydroxycumarinylacetate) on the level of some blood coagulation factors in relation to age].
    Nerad V; Chrobák L; Skaunic V; Hassmanová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1966; 9(4):605-8. PubMed ID: 5226690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Attempted determination of changes in the liver function in relation to age after a pelentan load].
    Nerad V; Chrobák L; Skaunic V; Hassmanová V
    Cesk Gastroenterol Vyz; 1966 Jan; 20(1):13-6. PubMed ID: 5910230
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of a derivative of 4-hydroxy-coumarin: 3(alfa-acetonyl-p-nitrobenzyl)4-hydroxy-coumarin (Sintrom) in man].
    Blatrix C; Charonnat S; Tillement JP; Israel J; Brevet JP; Debraux J; Merlin M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):984-95. PubMed ID: 4185223
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of acetylsalicylic acid in anticoagulation therapy].
    Barth P; Walter E; Zimmermann R; Weber E
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1854-9. PubMed ID: 4564650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.